Loading…

PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway

Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of prese...

Full description

Saved in:
Bibliographic Details
Published in:BMC women's health 2024-01, Vol.24 (1), p.25-25, Article 25
Main Authors: Yang, Xiaoyan, A, Min, Gegen, Tana, Daoerji, Badema, Zheng, Yue, Wang, Aiming
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3
container_end_page 25
container_issue 1
container_start_page 25
container_title BMC women's health
container_volume 24
creator Yang, Xiaoyan
A, Min
Gegen, Tana
Daoerji, Badema
Zheng, Yue
Wang, Aiming
description Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS. The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR). DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway. Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling.
doi_str_mv 10.1186/s12905-023-02872-5
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ddfb52e472bb49668c80cbb317dc533d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A778492863</galeid><doaj_id>oai_doaj_org_article_ddfb52e472bb49668c80cbb317dc533d</doaj_id><sourcerecordid>A778492863</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3</originalsourceid><addsrcrecordid>eNptkk9vFCEYxidGY2v1C3gwJF68bIUBBuZkNo3axk3cQz2Tlz8zw2Z2WGFmm41fXqZba9cYQiDwvD_g4SmKtwRfEiKrj4mUNeYLXNLcpSgX_FlxTlieVFKw50_mZ8WrlDYYEyG5eFmcUUkk4xU5L36tr1frNUF-6Lz2Y0Jj51Abw93YIRgsAheD9ga1_cGE_pB8QmBGv_fjAYUGddMWBhT2EH0e2wjD1ENExvX9jIpharvMvi-B0Q8tWn67RTsYuzs4vC5eNNAn9-ZhvCh-fPl8e3W9WH3_enO1XC0MJ3xccFxWHIPEYAVjUktWY8DUWWo5ddpozrWFphK8Ai5rQgUua00abYxtyrqhF8XNkWsDbNQu-i3Egwrg1f1CiK2COHrTO2Vto3npsm9as7qqpJHYaE2JsIZTajPr05G1m_TWWeOGMUJ_Aj3dGXyn2rBXBAtBKsEy4cMDIYafk0uj2vo0GwaDC1NSZZ0_l1FRyyx9_490E6Y4ZK9mFSslYzX_q2ohv8APTcgHmxmqlkJkt0pZ0ay6_I8qN-u23oTBNT6vnxSUxwITQ0rRNY-PJFjN-VPH_KmcP3WfPzXf5d1Tex5L_gSO_gY6lda2</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2914284495</pqid></control><display><type>article</type><title>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database</source><creator>Yang, Xiaoyan ; A, Min ; Gegen, Tana ; Daoerji, Badema ; Zheng, Yue ; Wang, Aiming</creator><creatorcontrib>Yang, Xiaoyan ; A, Min ; Gegen, Tana ; Daoerji, Badema ; Zheng, Yue ; Wang, Aiming</creatorcontrib><description>Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS. The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR). DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway. Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling.</description><identifier>ISSN: 1472-6874</identifier><identifier>EISSN: 1472-6874</identifier><identifier>DOI: 10.1186/s12905-023-02872-5</identifier><identifier>PMID: 38184561</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acidification ; AKT signaling ; Analysis ; Apoptosis ; Care and treatment ; Cell growth ; Diagnosis ; Enzymes ; Female ; Glucose metabolism ; Glycolysis ; Health aspects ; Hormones, Sex ; Humans ; Infertility ; Kinases ; Measurement ; Metabolism ; Motility ; Nuclear Proteins ; Ovaries ; PHLPP1 ; Phosphatases ; Phosphoprotein Phosphatases - genetics ; Polycystic Ovary Syndrome ; Proteins ; Proto-Oncogene Proteins c-akt ; Reactive Oxygen Species ; Sperm ; Stein-Leventhal syndrome</subject><ispartof>BMC women's health, 2024-01, Vol.24 (1), p.25-25, Article 25</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771674/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2914284495?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38184561$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Xiaoyan</creatorcontrib><creatorcontrib>A, Min</creatorcontrib><creatorcontrib>Gegen, Tana</creatorcontrib><creatorcontrib>Daoerji, Badema</creatorcontrib><creatorcontrib>Zheng, Yue</creatorcontrib><creatorcontrib>Wang, Aiming</creatorcontrib><title>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</title><title>BMC women's health</title><addtitle>BMC Womens Health</addtitle><description>Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS. The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR). DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway. Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling.</description><subject>Acidification</subject><subject>AKT signaling</subject><subject>Analysis</subject><subject>Apoptosis</subject><subject>Care and treatment</subject><subject>Cell growth</subject><subject>Diagnosis</subject><subject>Enzymes</subject><subject>Female</subject><subject>Glucose metabolism</subject><subject>Glycolysis</subject><subject>Health aspects</subject><subject>Hormones, Sex</subject><subject>Humans</subject><subject>Infertility</subject><subject>Kinases</subject><subject>Measurement</subject><subject>Metabolism</subject><subject>Motility</subject><subject>Nuclear Proteins</subject><subject>Ovaries</subject><subject>PHLPP1</subject><subject>Phosphatases</subject><subject>Phosphoprotein Phosphatases - genetics</subject><subject>Polycystic Ovary Syndrome</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Reactive Oxygen Species</subject><subject>Sperm</subject><subject>Stein-Leventhal syndrome</subject><issn>1472-6874</issn><issn>1472-6874</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk9vFCEYxidGY2v1C3gwJF68bIUBBuZkNo3axk3cQz2Tlz8zw2Z2WGFmm41fXqZba9cYQiDwvD_g4SmKtwRfEiKrj4mUNeYLXNLcpSgX_FlxTlieVFKw50_mZ8WrlDYYEyG5eFmcUUkk4xU5L36tr1frNUF-6Lz2Y0Jj51Abw93YIRgsAheD9ga1_cGE_pB8QmBGv_fjAYUGddMWBhT2EH0e2wjD1ENExvX9jIpharvMvi-B0Q8tWn67RTsYuzs4vC5eNNAn9-ZhvCh-fPl8e3W9WH3_enO1XC0MJ3xccFxWHIPEYAVjUktWY8DUWWo5ddpozrWFphK8Ai5rQgUua00abYxtyrqhF8XNkWsDbNQu-i3Egwrg1f1CiK2COHrTO2Vto3npsm9as7qqpJHYaE2JsIZTajPr05G1m_TWWeOGMUJ_Aj3dGXyn2rBXBAtBKsEy4cMDIYafk0uj2vo0GwaDC1NSZZ0_l1FRyyx9_490E6Y4ZK9mFSslYzX_q2ohv8APTcgHmxmqlkJkt0pZ0ay6_I8qN-u23oTBNT6vnxSUxwITQ0rRNY-PJFjN-VPH_KmcP3WfPzXf5d1Tex5L_gSO_gY6lda2</recordid><startdate>20240106</startdate><enddate>20240106</enddate><creator>Yang, Xiaoyan</creator><creator>A, Min</creator><creator>Gegen, Tana</creator><creator>Daoerji, Badema</creator><creator>Zheng, Yue</creator><creator>Wang, Aiming</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7R6</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>888</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQGEN</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>QXPDG</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240106</creationdate><title>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</title><author>Yang, Xiaoyan ; A, Min ; Gegen, Tana ; Daoerji, Badema ; Zheng, Yue ; Wang, Aiming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acidification</topic><topic>AKT signaling</topic><topic>Analysis</topic><topic>Apoptosis</topic><topic>Care and treatment</topic><topic>Cell growth</topic><topic>Diagnosis</topic><topic>Enzymes</topic><topic>Female</topic><topic>Glucose metabolism</topic><topic>Glycolysis</topic><topic>Health aspects</topic><topic>Hormones, Sex</topic><topic>Humans</topic><topic>Infertility</topic><topic>Kinases</topic><topic>Measurement</topic><topic>Metabolism</topic><topic>Motility</topic><topic>Nuclear Proteins</topic><topic>Ovaries</topic><topic>PHLPP1</topic><topic>Phosphatases</topic><topic>Phosphoprotein Phosphatases - genetics</topic><topic>Polycystic Ovary Syndrome</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Reactive Oxygen Species</topic><topic>Sperm</topic><topic>Stein-Leventhal syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Xiaoyan</creatorcontrib><creatorcontrib>A, Min</creatorcontrib><creatorcontrib>Gegen, Tana</creatorcontrib><creatorcontrib>Daoerji, Badema</creatorcontrib><creatorcontrib>Zheng, Yue</creatorcontrib><creatorcontrib>Wang, Aiming</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>GenderWatch</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>GenderWatch (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest Women's &amp; Gender Studies</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Diversity Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC women's health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Xiaoyan</au><au>A, Min</au><au>Gegen, Tana</au><au>Daoerji, Badema</au><au>Zheng, Yue</au><au>Wang, Aiming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</atitle><jtitle>BMC women's health</jtitle><addtitle>BMC Womens Health</addtitle><date>2024-01-06</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><spage>25</spage><epage>25</epage><pages>25-25</pages><artnum>25</artnum><issn>1472-6874</issn><eissn>1472-6874</eissn><abstract>Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS. The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR). DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway. Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38184561</pmid><doi>10.1186/s12905-023-02872-5</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1472-6874
ispartof BMC women's health, 2024-01, Vol.24 (1), p.25-25, Article 25
issn 1472-6874
1472-6874
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ddfb52e472bb49668c80cbb317dc533d
source PubMed Central (Open Access); Publicly Available Content Database
subjects Acidification
AKT signaling
Analysis
Apoptosis
Care and treatment
Cell growth
Diagnosis
Enzymes
Female
Glucose metabolism
Glycolysis
Health aspects
Hormones, Sex
Humans
Infertility
Kinases
Measurement
Metabolism
Motility
Nuclear Proteins
Ovaries
PHLPP1
Phosphatases
Phosphoprotein Phosphatases - genetics
Polycystic Ovary Syndrome
Proteins
Proto-Oncogene Proteins c-akt
Reactive Oxygen Species
Sperm
Stein-Leventhal syndrome
title PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A47%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PHLPP1%20inhibits%20the%20growth%20and%20aerobic%20glycolysis%20activity%20of%20human%20ovarian%20granular%20cells%20through%20inactivating%20AKT%20pathway&rft.jtitle=BMC%20women's%20health&rft.au=Yang,%20Xiaoyan&rft.date=2024-01-06&rft.volume=24&rft.issue=1&rft.spage=25&rft.epage=25&rft.pages=25-25&rft.artnum=25&rft.issn=1472-6874&rft.eissn=1472-6874&rft_id=info:doi/10.1186/s12905-023-02872-5&rft_dat=%3Cgale_doaj_%3EA778492863%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2914284495&rft_id=info:pmid/38184561&rft_galeid=A778492863&rfr_iscdi=true